The Ensign Group Inc logo

The Ensign Group Inc(ENSG)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 12 days
PROFIT SINCE LAST BUY
+1.12% ▲
LAST CLOSE
$188.41
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ENSG

11/13/2026: ENSG (1-star) has a low Upturn Star Rating. Not recommended to BUY.

The Ensign Group is a healthcare company focused on skilled nursing, rehabilitative care, home health, and hospice services. The company has a leading position in the industry, largely due to its decentralized management model and a consistent track record of improving the performance of acquired facilities. The primary growth story revolves around the long-term demand from an aging U.S. population and the continued consolidation of the post-acute care market. Risks include dependency on government reimbursement, labor shortages, and regulatory oversight. The stock may suit growth-oriented investors looking for exposure to the healthcare sector, though it is less suited for those seeking significant dividend income.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe company has a consistent track record of double-digit revenue growth through strategic acquisitions.
Momentum investorStrong fit while signal remains positiveThe stock often tracks positive trends in long-term care demand and successful operational turnarounds.
Value investorMixed fitThe stock often trades at a premium multiple due to its proven growth engine, which may deter traditional deep-value investors.
Dividend investorWeak fitThe company prioritizes reinvesting capital for growth over providing a high dividend yield.
Low-risk investorMedium fitWhile the business model is resilient, the stock is subject to healthcare regulatory and labor market risks.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock can be sensitive to broader healthcare sector sentiment and regulatory news.
Valuation riskMediumMarket expectations for growth are often high, which can lead to valuation sensitivity.
Competition risk (labor and service)HighCompeting for qualified nursing staff is a constant challenge that directly impacts operating costs.
Business qualityStrongThe company has a long history of operational excellence and effective capital allocation.
Dividend incomeLowIncome-focused investors may find the low yield and growth-focused payout policy insufficient.
Execution riskMediumThe company's strategy relies on the successful turnaround of new acquisitions, which is not always guaranteed.

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 10.99B USD
Price to earnings Ratio 28.04
1Y Target Price 225.8
Price to earnings Ratio 28.04
1Y Target Price 225.8
Volume (30-day avg) 379.2K shares
Beta 0.65
52 Weeks Range 141.47 - 217.76
Updated Date 11/13/2026
52 Weeks Range 141.47 - 217.76
Updated Date 11/13/2026
Dividends yield (FY) 0.14%
Basic EPS (TTM) 6.72

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 33.47%
Avg. Invested days 51
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ENSG receives a 3-star rating, supported by solid company fundamentals, solid quantitative characteristics, and solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
ENSG has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, solid earnings growth (+15.4%) and solid cash generation (FCF margin 7.3%) are partially offset by soft profitability (net margin 6.8%), modest insider ownership of 3.53%.

Financial Health Rating

★★★★★
ENSG's financial health is supported by solid cash strength, including free-cash-flow generation (7.3% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is ENSG's strongest growth driver at +96.2% FY2025 versus FY2024 (strong, 5 stars). Revenue growth (+18.7%, solid) and earnings growth (+15.4%, solid) are also constructive, though not equally high across every growth measure.

Ownership

★★★★★
Institutional ownership is 91.8% and approximately 95.5% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 3.53% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 10.02%
Baillie Gifford & Co Limited. 8.62%
Vanguard Portfolio Management, LLC 4.91%
Vanguard Capital Management, LLC 4.50%
FMR Inc 4.35%

Unit Economics (Per $1K Revenue)

★★★★★
ENSG generates approximately $158 of gross profit, $84 of operating income, and $73 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Soft margins explain the 2-star rating, with solid cash conversion and soft capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 24.44%

Quantitative Style Profile

★★★★★
ENSG has a large-cap, liquid, relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilityLarge / Mega Cap StabilityHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Skilled NursingPost-acute medical care, rehabilitation, and long-term nursing.This is the core engine, turning around facilities to provide essential medical care.
Home Health & HospiceClinical and end-of-life care in patient homes.This offers higher-margin, scalable services outside of physical facilities.
Senior LivingAssisted and independent living residential services.Provides stable, long-term residential revenue streams.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-10-27
When After Market
Estimate 1.75
Actual 1.79

Profitability

Profit Margin 7.03%
Operating Margin (TTM) 8.85%

Management Effectiveness

Return on Assets (TTM) 5.59%
Return on Equity (TTM) 17.05%

Valuation

Trailing PE 28.04
Forward PE 21.37
Enterprise Value 12.78B
Price to Sales(TTM) 1.94
Enterprise Value 12.78B
Price to Sales(TTM) 1.94
Enterprise Value to Revenue 2.25
Enterprise Value to EBITDA 19.33
Shares Outstanding 58.34M
Shares Floating 55.70M
Shares Outstanding 58.34M
Shares Floating 55.70M
Percent Insiders 3.53
Percent Institutions 91.85

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.